These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 30268316

  • 1. No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes.
    Skoll A, Boutin A, Bujold E, Burrows J, Crane J, Geary M, Jain V, Lacaze-Masmonteil T, Liauw J, Mundle W, Murphy K, Wong S, Joseph KS.
    J Obstet Gynaecol Can; 2018 Sep; 40(9):1219-1239. PubMed ID: 30268316
    [Abstract] [Full Text] [Related]

  • 2. Vaginal delivery of breech presentation.
    Kotaska A, Menticoglou S, Gagnon R, MATERNAL FETAL MEDICINE COMMITTEE.
    J Obstet Gynaecol Can; 2009 Jun; 31(6):557-566. PubMed ID: 19646324
    [Abstract] [Full Text] [Related]

  • 3. Technical Update No. 439: Antenatal Corticosteroids at Late Preterm Gestation.
    Liauw J, Foggin H, Socha P, Crane J, Joseph KS, Burrows J, Lacaze-Masmonteil T, Jain V, Boutin A, Hutcheon J.
    J Obstet Gynaecol Can; 2023 Jun; 45(6):445-457.e2. PubMed ID: 36572248
    [Abstract] [Full Text] [Related]

  • 4. [Prevention of preterm birth complications by antenatal corticosteroid administration].
    Schmitz T.
    J Gynecol Obstet Biol Reprod (Paris); 2016 Dec; 45(10):1399-1417. PubMed ID: 27776846
    [Abstract] [Full Text] [Related]

  • 5. SOGC Clinical Practice Guideline. Magnesium sulphate for fetal neuroprotection.
    Magee L, Sawchuck D, Synnes A, von Dadelszen P, MAGNESIUM SULPHATE FOR FETAL NEUROPROTECTION CONSENSUS COMMITTEE, MATERNAL FETAL MEDICINE COMMITTEE.
    J Obstet Gynaecol Can; 2011 May; 33(5):516-529. PubMed ID: 21639972
    [Abstract] [Full Text] [Related]

  • 6. No. 376-Magnesium Sulphate for Fetal Neuroprotection.
    Magee LA, De Silva DA, Sawchuck D, Synnes A, von Dadelszen P.
    J Obstet Gynaecol Can; 2019 Apr; 41(4):505-522. PubMed ID: 30879485
    [Abstract] [Full Text] [Related]

  • 7. Antenatal corticosteroids beyond 34 weeks gestation: What do we do now?
    Kamath-Rayne BD, Rozance PJ, Goldenberg RL, Jobe AH.
    Am J Obstet Gynecol; 2016 Oct; 215(4):423-30. PubMed ID: 27342043
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
    Mottola MF, Davenport MH, Ruchat SM, Davies GA, Poitras V, Gray C, Jaramillo Garcia A, Barrowman N, Adamo KB, Duggan M, Barakat R, Chilibeck P, Fleming K, Forte M, Korolnek J, Nagpal T, Slater L, Stirling D, Zehr L.
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Guidelines for the management of vasa previa.
    Gagnon R, DIAGNOSTIC IMAGING COMMITTEE, MATERNAL FETAL MEDICINE COMMITTEE.
    J Obstet Gynaecol Can; 2009 Aug; 31(8):748-753. PubMed ID: 19772710
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Guideline No. 392-Pregnancy and Maternal Obesity Part 2: Team Planning for Delivery and Postpartum Care.
    Maxwell C, Gaudet L, Cassir G, Nowik C, McLeod NL, Jacob CÉ, Walker M.
    J Obstet Gynaecol Can; 2019 Nov; 41(11):1660-1675. PubMed ID: 31640866
    [Abstract] [Full Text] [Related]

  • 15. Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes: Balancing Benefits and Risks.
    Boutin A, Skoll A, Bujold E, Burrows J, Crane J, Geary M, Jain V, Lacaze-Masmonteil T, Liauw J, Mundle W, Murphy K, Wong S, Joseph KS.
    J Obstet Gynaecol Can; 2018 Sep; 40(9):1193-1197. PubMed ID: 30268314
    [No Abstract] [Full Text] [Related]

  • 16. No. 347-Obstetric Management at Borderline Viability.
    Ladhani NNN, Chari RS, Dunn MS, Jones G, Shah P, Barrett JFR.
    J Obstet Gynaecol Can; 2017 Sep; 39(9):781-791. PubMed ID: 28859764
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes.
    Battarbee AN, Ros ST, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, Huang H, Andrews W, Saade G, Sadovsky Y, Reddy UM, Varner MW, Manuck TA, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN-PBR).
    Am J Obstet Gynecol MFM; 2020 Feb; 2(1):100077. PubMed ID: 32905377
    [Abstract] [Full Text] [Related]

  • 20. Time interval from late preterm antenatal corticosteroid administration to delivery and the impact on neonatal outcomes.
    Gulersen M, Gyamfi-Bannerman C, Greenman M, Lenchner E, Rochelson B, Bornstein E.
    Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100426. PubMed ID: 34153514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.